Geneva / India:
In a proud moment for India, Naman Gosalia is taking the India-born healthcare initiative AnginaX into global healthcare and public health conversations alongside presidents of leading cardiology societies, international healthcare leaders, policymakers, institutions, and public health stakeholders from around the world.
Gosalia’s consistent advocacy for making cardiovascular prevention the default rather than optional has led to invitations to discussions connected with forums associated with the World Heart Federation, as well as broader health policy conversations aligned with the United Nations ecosystem, where preventive healthcare is increasingly emerging as a global priority.
For decades, healthcare systems worldwide have largely focused on treating heart attacks after they occur. Gosalia believes the future of healthcare will instead be defined by preventing them before they begin.
At a time when cardiovascular disease claims nearly 18 million lives annually, according to the World Health Organization, Gosalia has become a prominent voice advocating for earlier intervention in healthcare, before symptoms emerge, before emergencies occur, and before patients reach catastrophic stages of disease.
As Founder of AnginaX, he is building a prevention-first cardiovascular model designed to combine advanced medical science, preventive pathways, and intelligent systems into a continuous approach to lifelong cardiovascular health. The mission is both ambitious and deeply human: ensuring individuals do not enter the healthcare system for the first time only after a medical crisis has begun.
During a recent appearance on the GunjanShouts podcast, Gosalia explained the philosophy behind the initiative:
“Our fight is against the disease. We don’t want to save lives only at the ICU; we want to protect lives much earlier, while people are still at home.”
His message is increasingly resonating with clinicians, hospitals, policymakers, and public health stakeholders exploring how prevention can become a continuous layer integrated into routine healthcare delivery at population scale.
Through AnginaX, Gosalia has brought together cardiologists, physicians, scientists, researchers, engineers, and technologists around a shared mission: shifting healthcare from reactive treatment toward continuous cardiovascular health building.
Rather than treating prevention as occasional screening, the model focuses on enabling earlier awareness and intervention before cardiovascular disease progresses toward angina, heart attack, stroke, or other life-threatening events.
Healthcare systems globally continue to face rising chronic disease burdens, escalating emergency care costs, and overstretched infrastructure. In this environment, prevention is no longer viewed as a long-term aspiration. Increasingly, it is becoming a necessity.
For many across India, AnginaX represents a proud milestone: an India-born prevention vision beginning to influence how the world approaches cardiovascular health at scale.
Even as conversations around AnginaX continue expanding internationally, Gosalia’s central message remains clear:
“The future of healthcare will not be defined by how well we treat heart attacks, but by how effectively we prevent them.”